重组Anti-LOXL2抗体[EPR12733] - C-terminal
Anti-LOXL2 antibody [EPR12733] - C-terminal
- RabMAb
- Recombinant
- KO Validated
- 了解详情
4
(6 Reviews)
|
(18 Publications)
Rabbit Recombinant Monoclonal LOXL2 antibody. C-terminal. Suitable for WB and reacts with Human samples. Cited in 18 publications.
查看别名
Lysyl oxidase homolog 2, Lysyl oxidase-like protein 2, Lysyl oxidase-related protein 2, Lysyl oxidase-related protein WS9-14, LOXL2
- WB
Lab
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (AB179810)
Lanes 1-4 : Merged signal (red and green). Green - ab179810 observed at 105 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab179810 Anti-LOXL2 antibody [EPR12733] - C-terminal was shown to specifically react with LOXL2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab261804 (knockout cell lysate ab257168) was used. Wild-type and LOXL2 knockout samples were subjected to SDS-PAGE. ab179810 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (ab179810) at 1/500 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
LOXL2 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human LOXL2 knockout HeLa cell line (<a href='/products/cell-lines/human-loxl2-knockout-hela-cell-line-ab261804'>ab261804</a>)
Lane 3:
HeLa treated with 0.5nM CoCl2 for 6 hours whole cell lysate at 20 µg
Lane 4:
Untreated HeLa cell lysate at 20 µg
Predicted band size: 87 kDa
Observed band size: 105 kDa
false
- WB
Lab
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (AB179810)
Exposure time :
Lane 1-3 : 3min
Lane 4 : 1min
Blocking/Diluting buffer and concentration 5% NFDM /TBST
MCF-7 lack LOXL2 expression (PMID : 19330836, PMID : 12154058 and PMID : 27655685)
Lanes 1, 2 and 4:
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (ab179810) at 1/1000 dilution
Lane 3:
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (ab179810) at 1/200 dilution
Lane 1:
MCF-7 (Human breast carcinoma) whole cell lysate at 10 µg
Lane 2:
MDA-MB-435 (Human ductal carcinoma) whole cell lysate at 10 µg
Lane 3:
A431 (Human epidermoid carcinoma) whole cell lysate at 10 µg
Lane 4:
U87-MG (Human glioblastoma) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 87 kDa
Observed band size: 105 kDa
false
- WB
Lab
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (AB179810)
Lanes 1-4 : Merged signal (red and green). Green - ab179810 observed at 105 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab179810 Anti-LOXL2 antibody [EPR12733] - C-terminal was shown to specifically react with LOXL2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab264807 (knockout cell lysate ab257166) was used. Wild-type and LOXL2 knockout samples were subjected to SDS-PAGE. ab179810 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (ab179810) at 1/500 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
LOXL2 knockout HeLa cell lysate at 20 µg
Lane 3:
HeLa treated with 0.5nM CoCl2 for 6 hours whole cell lysate at 20 µg
Lane 4:
Untreated HeLa cell lysate at 20 µg
Predicted band size: 87 kDa
Observed band size: 105 kDa
false
- WB
Lab
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (AB179810)
Lanes 1-4 : Merged signal (red and green). Green - ab179810 observed at 105 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab179810 Anti-LOXL2 antibody [EPR12733] - C-terminal was shown to specifically react with LOXL2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab261804 (knockout cell lysate ab257168) was used. Wild-type and LOXL2 knockout samples were subjected to SDS-PAGE. ab179810 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (ab179810) at 1/500 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
LOXL2 knockout HeLa cell lysate at 20 µg
Lane 4:
Untreated HeLa cell lysate at 20 µg
Predicted band size: 87 kDa
Observed band size: 105 kDa
false
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (18)
Recent publications for all applications. Explore the full list and refine your search
American journal of physiology. Heart and circulatory physiology 327:H642-H659 PubMed39028284
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of thoracic disease 16:581-592 PubMed38410543
2024
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 11:e15656 PubMed37038896
2023
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 6:375 PubMed37029269
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:974614 PubMed36185284
2022
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 11:2013-2025 PubMed35966289
2022
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 4:840 PubMed34226627
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34013363
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:480 PubMed32296422
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 43:1641-1649 PubMed32323822
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com